SNC
BIOL

Stifel Nicolaus & Co’s Biolase, Inc. BIOL Stock Holding History

Stifel Nicolaus & Co’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$64.7K Hold
3
– – ﹤0.01% 1455
2013
Q2 		$117K Buy
+3
New +$168K ﹤0.01% 1328

Other funds holding BIOL

CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Stifel Nicolaus & Co's BIOL Position: Q3 2013 in Review

Stifel Nicolaus & Co held its Biolase, Inc. (BIOL) position steady in Q3 2013 at 3 shares worth $64.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Stifel Nicolaus & Co first reported a position in BIOL in Q2 2013 and has held it in 2 quarters since. The position peaked at $117K in Q2 2013. 44 funds tracked by Wall St. Rank hold BIOL as of Q3 2013.

  • Stifel Nicolaus & Co held 3 shares of Biolase, Inc. worth $64.7K as of Q3 2013.
  • Stifel Nicolaus & Co left its Biolase, Inc. share count unchanged in Q3 2013.
  • Biolase, Inc. made up ﹤0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1455 holding.
  • Stifel Nicolaus & Co first reported a position in Biolase, Inc. in Q2 2013 and has held it in 2 quarters since.
  • Stifel Nicolaus & Co's Biolase, Inc. position peaked at $117K in Q2 2013.
  • 44 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.